BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/20/2014 10:04:00 AM | Browse: 1177 | Download: 1287
 |
Received |
|
2013-11-03 19:51 |
 |
Peer-Review Started |
|
2013-11-04 19:50 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-01-12 17:35 |
 |
Revised |
|
|
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-06-11 12:25 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-06-11 12:33 |
 |
Articles in Press |
|
2014-06-11 14:44 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-09-28 17:47 |
 |
Publish the Manuscript Online |
|
2014-10-20 10:04 |
| Category |
Hematology |
| Manuscript Type |
Minireviews |
| Article Title |
Myelofibrosis: Prognostication and cytoreductive treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Margherita Maffioli, Domenica Caramazza, Barbara Mora, Michele Merli and Francesco Passamonti |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Francesco Passamonti, MD
Division of Hematology, Department of Medicine
University Hospital Ospedale di Circolo e Fondazione Macchi
Viale L. Borri 57, 21100 Varese, Italy
Tel/Fax: +39 0332 393 648. E-mail francesco.passamonti@ospedale.varese.it |
| Key Words |
prognosis; momelotinib; fedratinib; ruxolitinib; Myelofibrosis |
| Core Tip |
The paper provides information on recent prognostication advances in myelofibrosis. In addition, efficacy/safety of ruxolitinib, fedratinib and momelotinib are discussed in detail |
| Publish Date |
2014-10-20 10:04 |
| Citation |
Maffioli M, Caramazza D, Mora B, Merli M, Passamonti F. Myelofibrosis: Prognostication and cytoreductive treatment. World J Hematol 2014; 3(3): 85-92 |
| URL |
http://www.wjgnet.com/2218-6204/full/v3/i3/85.htm |
| DOI |
http://dx.doi.org/10.5315/wjh.v3.i3.85 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345